Last: | $1.12 |
---|---|
Change Percent: | 0.85% |
Open: | $1.17 |
Close: | $1.12 |
High: | $1.19 |
Low: | $1.11 |
Volume: | 567,364 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.12 | $1.17 | $1.12 | $1.19 | $1.11 | 567,364 | 07-02-2024 |
$1.18 | $1.2 | $1.18 | $1.2 | $1.15 | 512,160 | 07-01-2024 |
$1.19 | $1.16 | $1.19 | $1.22 | $1.1 | 767,770 | 06-28-2024 |
$1.14 | $1.13 | $1.14 | $1.15 | $1.11 | 412,740 | 06-27-2024 |
$1.12 | $1.18 | $1.12 | $1.18 | $1.12 | 640,708 | 06-26-2024 |
$1.17 | $1.23 | $1.17 | $1.24 | $1.17 | 491,893 | 06-25-2024 |
$1.21 | $1.29 | $1.21 | $1.3 | $1.2 | 1,567,736 | 06-24-2024 |
$1.22 | $1.15 | $1.22 | $1.2985 | $1.13 | 1,648,455 | 06-21-2024 |
$1.16 | $1.11 | $1.16 | $1.22 | $1.05 | 1,551,214 | 06-20-2024 |
$1.06 | $1.21 | $1.06 | $1.2499 | $1.06 | 2,595,612 | 06-19-2024 |
$1.06 | $1.21 | $1.06 | $1.2499 | $1.06 | 2,595,612 | 06-18-2024 |
$1.25 | $1.11 | $1.25 | $1.38 | $0.81 | 6,171,965 | 06-17-2024 |
$1.5 | $1.52 | $1.5 | $1.7 | $1.465 | 4,055,048 | 06-14-2024 |
$1.45 | $1.47 | $1.45 | $1.47 | $1.43 | 809,136 | 06-13-2024 |
$1.45 | $1.45 | $1.45 | $1.47 | $1.42 | 1,217,590 | 06-12-2024 |
$1.42 | $1.4 | $1.42 | $1.44 | $1.4 | 531,929 | 06-11-2024 |
$1.41 | $1.36 | $1.41 | $1.46 | $1.36 | 916,692 | 06-10-2024 |
$1.45 | $1.44 | $1.45 | $1.46 | $1.41 | 552,168 | 06-07-2024 |
$1.47 | $1.49 | $1.47 | $1.51 | $1.44 | 622,710 | 06-06-2024 |
$1.48 | $1.42 | $1.48 | $1.49 | $1.42 | 685,451 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
SELLAS Life Sciences Group Inc. Company Name:
SLS Stock Symbol:
NASDAQ Market:
SELLAS Life Sciences Group Inc. Website:
- Acute Lymphoblastic Leukemia (ALL) is the Most Common Type of Cancer in Children – - Rare Pediatric Disease Designation (RPDD) Provides Eligibility for SLS009 to Receive a Priority Review Voucher (PRV) Upon Marketing Approval that can be Transferred/Sold to Other Parties – ...
2024-06-18 10:10:00 ET June 18, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform covering biotech and medical technology stocks releases the second of a two-part series looking at developments for the treatment of blood cancers, including AML, featuring A...
A look at the top 10 most actives in the United States Mustang Bio Inc. (MBIO) rose 141.4% to $0.3138 on volume of 161,736,322 shares ENDRA Life Sciences Inc. (NDRA) rose 13.7% to $0.117778 on volume of 79,058,950 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 27.2% to $0.1042 on volum...